At MedCity INVEST in Chicago, Jefferson Health's Dr. Stephen Klasko argued that we're on the brink of a consumer revolution, while CareMore Health's Dr. Sachin Jain believes we need to move to a system that proactively identifies patients' needs.
Faster cash burn rates, lack of growth in startup exits and sky-high valuations are leaving some industry observers nervous that a major market correction is on the way.
By reducing administrative burden and redesigning workflows around human needs, it creates space for what matters most: connection between clinicians and patients.
A panel of investors at the Digital Health Showcase in San Francisco weighed in where a direct-to-consumer model remains viable in digital health.
Influential healthcare executives such as Esther Dyson, angel investor par excellence; Dr. Stephen Klasko, president and CEO of Jefferson Health and Thomas Jefferson University; and Dr. Sachin Jain, president and CEO, CareMore Health will be speaking at INVEST 2019 and sharing their vision.
CSweetener, a nonprofit organization founded by Lisa Suennen and Lisa Serwin, functions as a Match.com of sorts for healthcare. It pairs women healthcare leaders with established male and female mentors.
Welcome to the senior VC club. Julie Sunderland of Biomatics Capital and Tracy Saxton of Pivotal bioVenture Partners closed their first funds this week, bringing fresh perspectives to the life science investment game.
Lisa Suennen shares her views on healthcare investment priorities and joining a corporate venture investor.
CSweetener aspires to become a national program that will use mentoring support for women healthcare entrepreneurs to improve the prospects for these businesses.
Geoff Clapp shares some insights into the challenges of healthcare entrepreneurs and some of the factors behind his previous business, Better's demise last year.
Contenders of the worst medical advice in history include: Smoking is good for you, bloodletting is a cure-all, and lobotomies cure mental illness.
Healthcare payments are no longer about transactions. It’s about controlling the revenue cycle. And increasingly, that control is not sitting with ISOs.
As Lisa Suennen said about this year's JP Morgan Healthcare Conference, "There was a lot of optimism about the convergence of biotech, life sciences and health IT, but also there was a sense of foreboding that the party is over in some of these areas."
This week we will be looking back at 2016 JP Morgan Healthcare Conference: what was said, the big news and what it means for the business of healthcare going forward.
Healthbox‘s decision to revamp its healthcare accelerator model was an interesting development but as Lisa Suennen, Venture Valkyrie blog author and consultant, it’s not an isolated case. She authored a report for the California HealthCare Foundation that provided a state of healthcare and life science accelerators in the U.S. and beyond last year. In response […]